Joori Park

Stock Analyst at Leerink Partners

(n/a)
# 4,321
Out of 4,670 analysts
1
Total ratings
n/a
Success rate
-20.05%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Joori Park

Larimar Therapeutics
Apr 3, 2024
Initiates: Outperform
Price Target: $25
Current: $6.16
Upside: +305.84%